Table 2.

Evaluation of factors associated with hyposmia/anosmia and dysgeusia in 423 healthcare workers with COVID-19 (Hospital das Clínicas, São Paulo, Brazil. January 22 - May 15, 2021).

	Hyposmia/anosmia						Dysgeusia
	Bivariate analysis			Multivariate analysis			Bivariate analysis			Multivariate analysis
	OR(95%CI)^a	p	Adj p^b	OR(95%CI)^a	p	Adj p^b	OR(95%CI)^a	p	Adj p^b	OR(95%CI^a	p	Adj p^b
Gamma variant	0.433(0.270–0.693)	< 0.001	< 0.001	0.303(0.176–0.522)	< 0.001	< 0.001	0.384(0.244–0.605)	< 0.001	< 0.001	0.385(0.221–0.672)	0.001	0.011
Previous COVID-19	1.630(0.606–4.381)	0.333	1.000	1.317(0.465–3.734)	0.604	1.000	1.626(0.586–4.507)	0.350	1.000	1.321(0.458–3.806)	0.607	1.000
Fully immunized^c	0.856(0.561–1.306)	0.470	1.000	1.657(0.989–2.779)	0.055	0.605	0.784(0.500–1.230)	0.290	1.000	1.334(0.779–2.286)	0.294	1.000
Duration of symptoms	1.084(0.990–1.186)	0.081	0.891	1.119(1.020–1.227)	0.017	0.187	1.097(1.000–1.204)	0.50	1.000	1.125(1.023–1.236)	0.015	0.165
Female	1.250(0.801–1.951)	0.326	1.000	0.802(0.503–1.279)	0.354	1.000	0.975(0.605–1.573)	0.918	1.000	1.071(0.652–1.759)	0.788	1.000
Age strata (years)
16–40	1 (ref)			1 (ref)			1 (ref)			1 (ref)
41–60	0.734(0.468–1.151)	0.178	1.000	0.639(0.397–1.026)	0.064	0.704	0.821(0.512–1.318)	0.414	1.000	0.730(0.446–1.196)	0.212	1.000
>60	0.416(0.137–1.261)	0.121	1.000	0.281(0.083–0.947)	0.041	0.451	0.559(0.184–1.702)	0.306	1.000	0.408(0.121–1.377)	0.149	1.000

Odds ratio (95% confidence interval).

Adjusted p-value for multiple comparisons (11 symptoms) according to Bonferroni's correction.

Recipients of two doses of a COVID-19 vaccine as of 14 days after the second dose.